Yüklüyor......
Mucin-based Targeted Pancreatic Cancer Therapy
The prognosis of pancreatic cancer (PC) patients is very poor with a five-year survival of less than 5%. One of the major challenges in developing new therapies for PC is the lack of expression of specific markers by pancreatic tumor cells. Mucins are heavily O-glycosylated proteins characterized by...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3530894/ https://ncbi.nlm.nih.gov/pubmed/22372499 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|